MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

SAGE Therapeutics Company Profile (NASDAQ:SAGE)

Consensus Ratings for SAGE Therapeutics (NASDAQ:SAGE) (?)
Ratings Breakdown: 7 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $87.57 (27.08% upside)

Analysts' Ratings History for SAGE Therapeutics (NASDAQ:SAGE)
Show:
DateFirmActionRatingPrice TargetActions
6/10/2015Canaccord GenuityBoost Price TargetBuy$85.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2015Cowen and CompanySet Price TargetBuy$95.00 -> $108.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2015Leerink SwannSet Price TargetBuy$107.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2015JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2015Leerink SwannBoost Price TargetOutperform$70.00 -> $93.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2015Cowen and CompanyInitiated CoverageOutperform$95.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/21/2015Canaccord GenuityBoost Price TargetBuy$58.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015Goldman SachsInitiated CoverageBuy$80.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015JPMorgan Chase & Co.Reiterated RatingBuy$58.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Canaccord GenuityReiterated RatingBuy$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Leerink SwannSet Price TargetBuy$54.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2015JPMorgan Chase & Co.Boost Price TargetOverweight$51.00 -> $58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2015Canaccord GenuitySet Price TargetBuy$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2015JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2015William BlairInitiated CoverageOutperform$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015Canaccord GenuitySet Price TargetBuy$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015Canaccord GenuityReiterated RatingBuy$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2015SunTrustInitiated CoverageBuy$67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2015Canaccord GenuityReiterated RatingBuy$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015JPMorgan Chase & Co.Reiterated RatingOverweight$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014Leerink SwannBoost Price TargetOutperform$46.00 -> $54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2014Goldman SachsUpgradeNeutral -> Buy$29.56 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2014Canaccord GenuityInitiated CoverageBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2014JPMorgan Chase & Co.Initiated CoverageOverweight$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2014Goldman SachsInitiated CoverageNeutral$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2014Leerink SwannInitiated CoverageOutperform$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/3/2013 forward)